710 results on '"Tang, W.H. Wilson"'
Search Results
2. Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices
3. Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure
4. Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient: A State-of-the-Art Review
5. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
6. Microbially Produced Imidazole Propionate Is Associated With Heart Failure and Mortality
7. Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV
8. Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial
9. Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression
10. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
11. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance
12. Pulmonary hypertension across the spectrum of left heart and lung disease
13. Retinal Microvasculature: A Potential Window Into Heart Failure Prevention
14. Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease
15. Burden of Pediatric Heart Failure in the United States
16. Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information
17. Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
18. Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis
19. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study
20. Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction
21. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults
22. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial
23. Consensus conference on heart-kidney transplantation
24. Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide
25. Long-Term Outcomes in Patients With a Left Ejection Fraction ≤15% Undergoing Cardiac Resynchronization Therapy
26. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure – insights from TRANSFORM‐HF.
27. Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center’s Experience
28. Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling
29. Effects of Pirfenidone on Echocardiographic Parameters of Left Ventricular Structure and Function in Patients with Idiopathic Pulmonary Fibrosis
30. Epigenetics in Cardiac Hypertrophy and Heart Failure
31. Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure
32. Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial
33. Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review
34. Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure.
35. The Utilization and Impact of Cardiovascular Specialists on Guideline‐Directed Medical Scores: An Analysis of a Diverse, Multi‐state, Electronic Health Record‐Based Registry
36. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release
37. Targeted Inhibition of Gut Microbial TMAO Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
38. L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
39. Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients
40. Sodium and potassium changes during decongestion with acetazolamide – a pre‐specified analysis from the ADVOR trial
41. Gut Microbiome-Based Management of Patients With Heart Failure
42. Screening for Dilated Cardiomyopathy in At-Risk First-Degree Relatives
43. Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy: Insights From INTERMACS
44. Intrarenal Flow Alterations During Transition From Euvolemia to Intravascular Volume Expansion in Heart Failure Patients
45. Patients Not Meeting PARADIGM-HF Enrollment Criteria Are Eligible for Sacubitril/Valsartan on the Basis of FDA Approval: The Need to Close the Gap
46. Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
47. Multiomics Insights to Accelerate Drug Development: Will They Hold Their Promises?
48. Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney
49. Virtual Versus In-Person Visits and Appointment No-Show Rates in Heart Failure Care Transitions
50. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.